(39 days)
The NobelDirect™ OD Implant is a root form endosseous implant intended to provide immediate retention for removable tissue supported lower dentures in fully edentulous patients.
The NobelDirect™ OD Implant is a root form endosseous implant intended to provide immediate retention for a removable tissue supported overdenture. The NobelDirect™ OD Implant is intended for placement in the interforaminal area of the anterior mandible for the fully edentulous lower arch.
Nobel Biocare's NobelDirect™ OD Implant is a threaded one-piece root form endossions with an integrated ball attachment designed for one-stage surgical procedures and overdenture restorations. The integratou ball attablimont as intended to provide immediate retention for removable tissue supported lower overdentures in fully edentulous jaws.
Nobel Biocare's NobelDirect™ OD Implant can be placed in an edentulous arch or piaced simultaneously Nobel Diocare 3 Nobel Biocare's Nobel Biocare's NobelDirect™ OD Implant in immediate function applications, it is essential to obtain primary implant stability. Nobel Biocare's Gold Cap for Ball Attachment is to be utilized with the NobelDirect™ OD Implant.
Nobel Biocare's NobelDirect™ OD Implant is machined from titanium and is available with a straight or tapered contour. The NobelDirect™ OD Implant has a surface treatment that consists of a titanium oxide layer (TiUnite) that extends over the implant threads and onto the implant collar.
This 510(k) premarket notification is for a dental implant, the NobelDirect™ OD Implant. The provided document does not contain information regarding specific acceptance criteria, a study proving device performance against such criteria, sample sizes for test or training sets, ground truth establishment methods, or details about expert involvement. This type of information is typically found in performance testing sections of a 510(k) submission, which are not present in this excerpt.
The document primarily focuses on:
- Device Description: What the NobelDirect™ OD implant is (threaded one-piece root form endosseous implant with an integrated ball attachment).
- Intended Use: For one-stage surgical procedures and overdenture restorations, providing immediate retention for removable tissue-supported lower overdentures in fully edentulous jaws.
- Indications for Use: Specifically stated as "a root form endosseous implant intended to provide immediate retention for removable tissue supported lower dentures in fully edentulous patients." The "Indications for Use" form also specifies "immediate retention for a removable tissue supported overdenture. The NobelDirect™ OD implant is indicated for use in the interforaminal area of the anterior mandible for the fully edentulous lower arch."
- Substantial Equivalence: Listing legally marketed predicate devices (Brånemark System Implants K022562 and Replace One-Piece Implants K023952) to establish substantial equivalence.
- FDA Clearance Letter: Confirming that the FDA has reviewed the 510(k) and determined the device is substantially equivalent to legally marketed predicate devices.
Therefore, I cannot populate the requested table or answer the specific questions about acceptance criteria and study details based on the provided text.
{0}------------------------------------------------
AUG 2 0 2004
510(k) Summary of Safety and Effectiveness 1.4
| Submitted by: | Elizabeth J. MasonSr. Regulatory Affairs Specialist |
|---|---|
| Address: | Nobel Biocare USA Inc.22715 Savi Ranch ParkwayYorba Linda, CA 92887 |
| Telephone: | (714) 282-4800, ext. 7830 |
| Facsimile: | (714) 998-9348 |
| Date of Submission: | July 9, 2004 |
| Classification Name: | Endosseous Implant (21 CFR 872.3640) |
| Trade or Proprietaryor Model Name: | NobelDirect™ OD Implant |
| Legally Marketed Device(s): | Brånemark System Implants (K022562)Replace One-Piece Implants (K023952) |
Device Description:
്ക് Nobel Biocare's NobelDirect™ OD Implant is a threaded one-piece root form endossions with an integrated ball attachment designed for one-stage surgical procedures and overdenture restorations. The integratou ball attablimont as intended to provide immediate retention for removable tissue supported lower overdentures in fully edentulous jaws.
Nobel Biocare's NobelDirect™ OD Implant can be placed in an edentulous arch or piaced simultaneously Nobel Diocare 3 Nobel Biocare's Nobel Biocare's NobelDirect™ OD Implant in immediate function applications, it is essential to obtain primary implant stability. Nobel Biocare's Gold Cap for Ball Attachment is to be utilized with the NobelDirect™ OD Implant.
Nobel Biocare's NobelDirect™ OD Implant is machined from titanium and is available with a straight or tapered contour. The NobelDirect™ OD Implant has a surface treatment that consists of a titanium oxide layer (TiUnite) that extends over the implant threads and onto the implant collar.
Indications for Use:
The NobelDirect™ OD Implant is a root form endosseous implant intended to provide immediate retention for removable tissue supported lower dentures in fully edentulous patients.
000009
{1}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/1/Picture/1 description: The image shows the seal of the Department of Health & Human Services - USA. The seal is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is an abstract symbol that resembles an eagle or bird in flight. The symbol is composed of three curved lines that represent the wings and body of the bird.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
AUG 2 0 2004
Ms. Elizabeth J. Mason Senior Regulatory Affairs Specialist Nobel Biocare USA. Incorporated 22715 Savi Ranch Parkway Yorba Linda, California 92887
Re: K041876
Trade/Device Name: NobelDirect™ OD Implant Regulation Number: 872.3640 Regulation Name: Endosseous Implant Regulatory Class: II Product Code: DZE Dated: July 9, 2004 Received: July 21, 2004
Dear Ms. Mason:
We have reviewed your Section 510(k) premarket notification of intent to market the device We have reviewed your Section 910(x) promised is substantially equivalent (for the referenced above and have determined are to legally marketed predicate devices marketed in indications for use stated in the encreating of the enactment date of the Medical Device interstate conments, or to thay 20, 1778, and the same with the provisions of Amendments, of to devices that have occi. Toot) that do not require approval of a premarket the Federal Pood, Drug, and Cosmette Por (recefore, subject to the general approval appreation (1 Mr.). Tou sees, controls provisions of the Act include controls provisions of the Fiel. "The ginners of devices, good manufacturing practice, requirements for nibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III If your device is classified (see above) into enotrels. Existing major regulations affecting (PMA), II may be subject to Sach additional Prairies of Parts 800 to 898. In your device can be found in the Code of Pecements concerning your device in the Federal Register.
{2}------------------------------------------------
Page 2 - Ms. Mason
Please be advised that FDA's issuance of a substantial equivalence determination does not Please be advised that IDA S Issuance of a substantes with other requirements
mean that FDA has made a determination that your device Federal agencies mean that FDA has made a decermination that no administered by other Federal agencies.
of the Act or any Federal statutes and regulations administered by powired to of the Act or any rederal statues and reguirements, including, but not limited to: registration
You must comply with all the Act's requirements . . . . . . . . . . . . . . . You must comply with an the Act 3 requirements and 801); good manufacturing practice
and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice and listing (21 CFR Fart 807), labeling (21 CFR Part 820); and if requirements as set form in the quality systems (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) This letter will anow you to begin manceant 7 500 stantial equivalence of your device to a premarket notification. THC I DA miaing or bassification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), a If you desire specific advice for your deries of the street. Also, please note the regulation please contact the Other or Comphanes and (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the may obtain offer general information on Jour Capper Assistance at its toll-free DIVIsion of Sman Manata (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Chiu Lin, Ph.D.
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{3}------------------------------------------------
Indications for Use
510(k) Number (if known):
KO41876
Device Name: NobelDirect'" OD Implant
Indications For Use:
The NobelDirect™ OD Implant is a root form endosseous implant intended to provide ime NobelDiroot - OB Thiplantes of Supported overdenture. The NobelDirect™ immediate fotorkion for a foraminal area of the anterior mandible for the fully edentulous lower arch.
X Prescription Use __ (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(Please do not WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Swam Purna
(Division Sign-Off) Division of Anesthesiology, General Hospital, Infection Control, Dental Devices
Page 1 of 1
510(k) Number. K091862
§ 872.3640 Endosseous dental implant.
(a)
Identification. An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.(b)
Classification. (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2)
Classification. Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use;
(ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads;
(iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system;
(iv) The device must be demonstrated to be biocompatible;
(v) Sterility testing must demonstrate the sterility of the device;
(vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment;
(vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians;
(viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and
(ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.